GlycoMimetics Inc.

NASDAQ: GLYC · Real-Time Price · USD
15.71
-0.44 (-2.72%)
At close: Jul 02, 2025, 3:58 PM

GlycoMimetics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a 54.09K n/a n/a n/a 10K n/a n/a n/a 75.00 n/a 75K n/a 18K 86.56K 142.00 1.06M
Cost of Revenue
n/a n/a n/a 8.13K n/a n/a 23.3K 269.94K 265.87K 262.96K 259.57K 256.03K 258.44K 258.12K 16.98K n/a n/a n/a
Gross Profit
n/a n/a 27.04K -8.13K n/a n/a -13.3K -269.94K -265.87K -262.96K -259.49K -256.03K -183.44K -258.12K 1.02K 86.56K 142.00 1.06M
Operating Income
-21.03M -2.4M -7.33M -11.23M -10.36M -11.12M -9.59M -9.81M -8.93M -10.94M -10.62M -8.77M -13.35M -14.66M -17.43M -17.34M -14.4M -14.28M
Interest Income
313K 55.14K 110.11K 184.52K 262.29K 378.36K 512.19K 610.98K 671.03K 581.67K 378.26K 243.6K 85.59K 7.07K 4.08K 4.63K 5.22K 5.85K
Pretax Income
n/a -2.34M -7.22M -9.82M -10.1M -10.74M -9.08M -9.2M -8.26M -10.36M -10.24M -8.52M -13.27M -14.65M -17.42M -17.33M -14.4M -14.27M
Net Income
n/a -2.34M -7.22M -9.82M -10.1M -10.74M -9.08M -9.2M -8.26M -9.78M -29.21M -8.28M -13.18M -14.65M -17.42M -17.33M -14.4M -14.27M
Selling & General & Admin
8.95M 2.38M 5.08M 4.01M 4.07M 5.09M 4.31M 4.52M 4.86M 5.52M 4.73M 3.85M 5.46M 5.06M 4.55M 4.14M 4.24M 4.19M
Research & Development
12.08M 14.78K 233.21K 1.72M 6.29M 6.03M 5.29M 5.29B 4.07M 5.42M 5.89M 4.92M 7.97M 9.6M 12.9M 13.28M 10.17M 11.15M
Other Expenses
n/a n/a 2.02M 5.51M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
21.03M 2.4M 7.33M 11.23M 10.36M 11.12M 9.6M 9.81M 8.93M 10.94M 10.62M 8.77M 13.43M 14.66M 17.44M 17.42M 14.4M 15.34M
Interest Expense
-1.07M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a 143.00 40.00 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
n/a 2.4M 7.33M 11.23M 10.36M 11.12M 9.6M 9.81M 8.93M 10.94M 10.62M 8.77M 13.43M 14.66M 17.44M 17.42M 14.4M 15.34M
Income Tax Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a -581.36K 18.97M -243.6K -85.59K -7.07K -294 -96 684.00 110.00
Shares Outstanding (Basic)
3.86B 64.52M 64.48M 64.48M 64.48M 64.46M 64.39M 64.35M 64.28M 60.35M 52.96M 52.42M 52.41M 52.33M 52.01M 51.56M 51.54M 50.7M
Shares Outstanding (Diluted)
3.86B 64.52M 64.48M 64.48M 64.48M 64.46M 64.39M 64.35M 64.28M 60.35M 52.96M 52.42M 52.41M 52.33M 52.01M 51.56M 51.54M 50.7M
EPS (Basic)
-4.93K -0.04 -0.11 -0.15 -0.16 -0.17 -0.14 -0.14 -0.13 -0.16 -0.55 -0.16 -0.25 -0.28 -0.33 -0.34 -0.28 -0.28
EPS (Diluted)
-4.93K -0.04 -0.11 -0.15 -0.16 -0.17 -0.14 -0.14 -0.13 -0.16 -0.55 -0.16 -0.25 -0.28 -0.33 -0.34 -0.28 -0.28
EBITDA
-21.03M -2.4M -5.31M -5.71M -10.35M -11.1M -9.57M -9.77M -8.89M -10.9M -10.58M -8.72M -13.3M -14.6M -17.36M -17.27M -14.34M -14.21M
EBIT
n/a -2.4M -5.31M -5.72M -10.36M -11.12M -9.59M -9.81M -8.93M -10.94M -10.62M -8.77M -13.35M -14.66M -17.43M -17.34M -14.4M -14.28M
Depreciation & Amortization
n/a n/a -35.17K 8.13K 12.42K 14.62K 23.3K 42.75K 43.42K 262.96K 259.57K 256.03K 258.44K 258.12K 255.72K 256.82K 252.42K 248.67K